| Design, setting and participants | Key Findings |
---|---|---|
Acutely unwell population | ||
The SPLIT trial. 2015 [27] | Multicentre, double-blind, cluster randomised, double crossover trial comparing 0.9 % saline with Plasma-Lyte 148®; n= 2262 | • There was no significant difference between group in rates of AKI or AKI requiring RRT • There was no significant difference between groups in survival to day 90 |
Smith et al. 2015 [28] | Single centre, double-blind RCT comparing 0.9 % saline with Plasma-Lyte A® in critically ill trauma patients; n=18 | • Patients receiving 0.9 % saline had significantly lower serum chloride and bicarbonate concentration • Patients receiving Plasma-Lyte A® had a quicker fibrin build up and cross linking (α angle) at 6 hours after infusion • No difference between groups in coagulation tests or blood products received at 6 hours |
Young et al. 2014 [29] | Single centre, double-blind RCT comparing 0.9 % saline with Plasma-Lyte A® in patient presenting to ED with severe acute trauma; n=46 | • Patients receiving 0.9 % saline had an increase in serum chloride concentration and decrease in serum pH • No significant differences in mortality hospital length of stay, blood transfusion requirements or utilization of resources |
Cieza et al. 2013 [30] | Single centre, open label RCT comparing 0.9 % saline with Ringer’s lactate in patients with severe dehydration secondary to choleriform diarrhea; n=40 | • Patients receiving 0.9 % saline had lower serum pH at 2 and 4 hours • No difference between in serum creatinine, lactate or potassium concentration |
Hasman et al. 2012 [31] | Single centre, double-blind RCT comparing either 0.9 % saline, Ringer's lactate or Plasma-Lyte® in patients presenting to ED with dehydration; n= 90 | • Patients receiving 0.9 % saline had a significantly lower serum pH and lower serum bicarbonate concentration • No difference between groups in chloride, potassium, or sodium concentrations |
Van Zyl et al. 2012 [32] | Multicentre, double-blind RCT of Ringer’s lactate versus 0.9 % saline in patients presenting to ED with diabetic ketoacidosis; n=54 | • There was no significant difference between groups in time interval for correction of acidosis • Patient receiving 0.9 % saline a significantly shorter time to lower blood glucose • No difference between groups in hospital length of stay |
Mahler et al. 2011 [33] | Single centre, double-blind RCT comparing either 0.9 % saline with Plasma-Lyte A® in patients presenting to ED with diabetic ketoacidosis; n= 45 | • Patients receiving 0.9 % saline had significantly higher serum chloride and lower bicarbonate concentration |
Wu et al. 2011 [34] | Multicentre, open label RCT comparing 0.9 % saline with Ringer’s lactate in patients diagnosed with acute pancreatitis; n=40 | • Patients receiving Ringer’s lactate had lower rates of SIRS and lower CRP concentration at 24 hours • No difference between groups in development of complications or hospital length of stay |
Cho et al. 2007 [35] | Multicentre, single-blind RCT of Ringer’s lactate versus 0.9 % saline in patients presenting to ED with rhabdomyolysis; n=28 | • Patients receiving 0.9 % saline had a significantly higher serum chloride and sodium concentration and lower serum pH • There was no significant difference between groups in time interval for normalisation of creatine kinase |
Surgical population | ||
The SPLIT- Major Surgery trial. 2015 | Prospective phase 4, single centre blinded study investigating the safety and efficacy of using 0.9 % saline with Plasma-Lyte® 148 as fluid therapy in adult patients undergoing major surgery; n=1100 | • There was no significant difference between groups in rates of AKI • There were no significant difference between groups in the development of postoperative complications or length of hospital stay • Patients who received 0.9 % saline developed a transient hyperchloremic metabolic acidosis on postoperative day 1 |
Potura et al. 2015 [36] | Single centre, open label RCT comparing 0.9 % saline with Elomel Isoton®(low chloride, acetate buffered crystalloid) in patients undergoing renal transplantation; n=150 | • Significantly more patients receiving 0.9 % saline required intra-operative inotrope support • Patients receiving 0.9 % saline had a significantly lower base excess and higher serum chloride concentration • No difference between groups in post-operative urine output, creatinine, blood urea nitrogen or need for RRT |
Song et al. 2015 [37] | Single centre, open label RCT comparing 0.9 % saline with Plasma-Lyte® in patients undergoing spinal surgery; n=50 | • Patients receiving 0.9 % saline had lower pH, base excess, and bicarbonate concentration and higher serum chloride concentration • Patients receiving Plasma-Lyte® had significantly higher urine output • No difference between groups in rotation thromboelastometry analysis, estimated blood loss or transfusion requirements |
Hafizah et al. 2015 [38] | Single centre, open label RCT comparing 0.9 % saline with Sterofundin® ISO patients undergoing neurosurgery (low chloride, acetate buffered crystalloid); n=30 | • Patients receiving 0.9 % saline had a significantly lower serum pH and higher serum chloride and sodium concentration |
Kim et al. 2013 [39] | Single centre, blinded RCT comparing either 0.9 % saline with Plasma-Lyte® in patients undergoing renal transplantation; n= 60 | • Patients receiving 0.9 % saline had lower pH and base excess values • No difference between groups in post-operative urine output, creatinine or need for RRT |
Modi et al. 2012 [40] | Single centre, double-blind RCT comparing 0.9 % saline with Ringer's lactate in patients undergoing renal transplantation; n= 74 | • Patients receiving 0.9 % saline had lower serum pH and base excess values • No difference between groups in post-operative urine output or creatinine |
Heidari et al. 2011 [41] | Single centre, double-blind RCT comparing 0.9 % saline with Ringer’s lactate and 5% saline in patients undergoing lower abdominal surgery; n=90 | • A higher proportion of patients that had received 0.9 % saline had experienced vomiting 6 hours post-operatively |
Hadimioglu et al. 2008 [42] | Single centre, double-blind RCT comparing either 0.9 % saline, Ringer's lactate or Plasma-Lyte® in patients undergoing renal transplantation; n= 90 | • Patients receiving 0.9 % saline had an increase in serum chloride concentration and decrease in serum pH • Patients receiving Ringer’s lactate had a significantly increased serum lactate concentration • There was no significant difference between in postoperative creatinine or need for RRT |
Khajavi et al. 2008 [43] | Single centre, double-blind RCT comparing 0.9 % saline with Ringer's lactate in patients undergoing renal transplantation; n= 52 | • Patient receiving 0.9 % saline had a significantly lower serum pH and higher serum potassium concentration at the end of the operation |
Chin et al. 2006 [44] | Single centre, open label RCT comparing 0.9 % saline with Ringer’s lactate, 0.9 % saline with dextrose 5 % in non-diabetic patients undergoing elective surgery; n=50 | • No difference between groups in serum urea, sodium or potassium concentration • Dextrose 5 % resulted in significant, albeit transient hyperglycemia, even in non-diabetic patients |
Karaca et al. 2006 [45] | Single centre, single-blinded RCT comparing 0.9 % saline with Ringer’s lactate and 4 % gelatin polysuccinate in patients undergoing transurethral prostatectomy under spinal anesthesia; n=60 | • No difference between groups nausea, vomiting, dizziness and post spinal hearing loss. |
Chanimov et al. 2006 [46] | Single centre, double-blinded RCT comparing 0.9 % saline with Ringer’s lactate in patients undergoing Cesarean section; n=40 | • No difference between groups in inotrope requirements • No significant differences in the Apgar scores at 1 and 5 min or infant well-being |
O’Malley et al. 2005 [47] | Single centre, double blind RCT comparing 0.9 % saline with Ringer’s lactate in patients undergoing renal transplantation; n=51 | • Significantly more patients receiving 0.9 % saline required intra-operative treatment for metabolic acidosis and hyperkalemia • No difference between groups in post-operative urine output, creatinine or need for RRT |
Takil et al. 2002 [48] | Single centre, open label RCT comparing 0.9 % saline with Ringer’s lactate in patients undergoing spinal surgery; n=30 | • Patients receiving 0.9 % saline had an increase in serum chloride, sodium concentration and decrease in serum pH • No difference between groups in intraoperative hemodynamic variables or hospital and ICU lengths of stay |
Waters et al. 2001 [49] | Single centre, double-blind RCT comparing 0.9 % saline with Ringer’s lactate in patients undergoing abdominal aortic aneurysm surgery; n=66 | • Patients receiving 0.9 % saline had an increase in serum chloride, sodium concentration and decrease in serum pH • Patients receiving 0.9 % saline received a greater volume of platelets • No difference between groups in estimated blood loss, postoperative complications, hospital and ICU lengths of stay |
Scheingraber et al. 1999 [50] | Single centre, open label RCT comparing 0.9 % saline with Ringer’s lactate in patients undergoing gynecologic surgery; n=24 | • Patients receiving 0.9 % saline had an increase in serum chloride concentration and decrease in serum pH |
Ramanathan et al. 1984 [551] | Single centre, open label RCT comparing 0.9 % saline with Ringer’s lactate, Ringer’s lactate with dextrose 5 % and Plasma-Lyte A® in patients undergoing Cesarean section; n=60 | • Patients receiving 0.9 % saline had an decrease in serum pH • No difference between groups in blood pressure or inotrope requirements |